CLINICAL TRIALS PROFILE FOR ARTHROTEC
✉ Email this page to a colleague
All Clinical Trials for ARTHROTEC
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00594854 ↗ | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec | Terminated | POZEN | Phase 3 | 2007-09-01 | This randomized, double-blind, parallel-group, controlled, multi-center clinical trial of 6 months duration is designed to assess the efficacy, tolerability and safety of PN400 versus diclofenac/misoprostol in subjects at high risk for developing NSAID-associated gastric ulcers. Approximately 100 sites will participate to enroll a total of 200 subjects (100 per arm). At least 20% of the subjects enrolled will be age 65 years and older. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ARTHROTEC
Condition Name
Clinical Trial Locations for ARTHROTEC
Trials by Country
Clinical Trial Progress for ARTHROTEC
Clinical Trial Phase
Clinical Trial Sponsors for ARTHROTEC
Sponsor Name